| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―15 |
Persistent CD4+ T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection |
Jadith Ziegler, Christina Lawrence, Nathan Pezant, Sean Turner, Nancy Redinger, Carla Guthridge, et al. (+8) Kenneth Smith, Jingrong Chen, Joel M. Guthridge, Judith A. James, Susannah M. Rankin, Linda F. Thompson, A. Darise Farris, Susan Kovats |
| 2 |
[GO] |
2025―Oct―27 |
Differential heterologous immunological effects induced by ChAdOx1-S and BNT162b2 COVID-19 vaccines |
Elisabeth A. Dulfer, Büsra Geckin, Martijn Zoodsma, Leonie S. Helder, Wenchao Li, Reinout van Crevel, et al. (+4) Josephine S. van der Maat, Yang Li, Jorge Domínguez-Andrés, Mihai G. Netea |
| 3 |
[GO] |
2025―Jun―14 |
Efficacy and safety of interferon alpha-2b aerosol therapy for patients infected with the SARS-CoV-2 omicron variant: A randomized controlled single-blind study |
Yinpeng Jin, Xianming Meng, Zhiping Qian, Jun Zhao, Ying Lv, Yun Ling, Xiaohong Fan |
| 4 |
[GO] |
2023―Mar―05 |
Expression of SARS-CoV-2 receptor angiotensin-converting enzyme 2 by activating protein-1 in human mast cells |
Hee-Yun Kim, Ho-Geun Kang, Hyung-Min Kim, Hyun-Ja Jeong |
| 5 |
[GO] |
2023―Feb―16 |
Vaccination against SARS-CoV-2 Using Extracellular Blebs Derived from Spike Protein-Expressing Dendritic Cells |
Jee Young Chung, Melissa N. Thone, Jenny E. Davies, Johannes S. Gach, D. Huw Davies, Donald N. Forthal, Young Jik Kwon |
| 6 |
[GO] |
2023―Feb―10 |
Weighted gene co-expression network-based identification of genetic effect of mRNA vaccination and previous infection on SARS-CoV-2 infection |
Yue He, Mengzi Sun, Yan Xu, Chengxiang Hu, Yanfang Wang, Yuan Zhang, et al. (+2) Jiaxin Fang, Lina Jin |
| 7 |
[GO] |
2022―Jun―10 |
Immune system changes in those with hypertension when infected with SARS-CoV-2 |
Sheng Su, Ruirong Chen, Shaofen Zhang, Haihua Shu, Jianfang Luo |
| 8 |
[GO] |
2022―Mar―12 |
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients |
Dinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, Alison Whitelegg |
| 9 |
[GO] |
2021―Nov―07 |
SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity |
Hanna Kim, Jae-Eun Byun, Suk Ran Yoon, Hashem Koohy, Haiyoung Jung, Inpyo Choi |
| 10 |
[GO] |
2021―Jun―20 |
An Outlook on Antigen-Specific Adoptive Immunotherapy for Viral Infections with a Focus on COVID-19 |
Seyed Mostafa Monzavi, Mahmood Naderi, Naser Ahmadbeigi, Abdol-Mohammad Kajbafzadeh, Samad Muhammadnejad |
| 11 |
[GO] |
2021―Apr―17 |
Functional responsiveness of memory T cells from COVID-19 patients |
Ece Tavukcuoglu, Utku Horzum, Ahmet Cagkan Inkaya, Serhat Unal, Gunes Esendagli |
| 12 |
[GO] |
2020―Dec―16 |
Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients |
Malgorzata Kloc, Rafik M. Ghobrial, Agnieszka Lipińska-Opałka, Agata Wawrzyniak, Robert Zdanowski, Boleslaw Kalicki, Jacek Z Kubiak |
| 13 |
[GO] |
2020―Oct―15 |
Evaluation of Mechanisms of Action of Re-Purposed Drugs for Treatment of COVID-19 |
Rajesh Rajaiah, Kandahalli V. Abhilasha, Mysore.A. Shekar, Stefanie N. Vogel, Bannikuppe S. Vishwanath |
| 14 |
[GO] |
2020―Jul―28 |
New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19? |
Pramod Kumar Gupta |
| 15 |
[GO] |
2020―Jun―13 |
Surviving the storm: Dealing with COVID-19 |
Arthur A. Vandenbark, Roberto Meza-Romero, Halina Offner |
| 16 |
[GO] |
2020―Apr―28 |
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection? |
Juliana Gil Melgaço, Tamiris Azamor, Ana Paula Dinis Ano Bom |
